TickerFacts.

Neogen Corp (NEOG): EPS (Diluted)

Annual figures by period end, from SEC filings.

Stock splits: 3-for-2, first reflected in a filing dated 2014-01-09; 4-for-3, first reflected in a filing dated 2018-01-05; 2-for-1, first reflected in a filing dated 2021-07-30. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

-$0.04
Year ended 2026-05-31
$1.212010-05-31: $0.762011-05-31: $0.962012-05-31: $0.622013-05-31: $0.752014-05-31: $0.762015-05-31: $0.902016-05-31: $0.722017-05-31: $0.862018-05-31: $1.212019-05-31: $0.572020-05-31: $0.562021-05-31: $0.572022-05-31: $0.452023-05-31: -$0.122024-05-31: -$0.042025-05-31: -$5.032026-05-31: -$0.04-$0.04
2010-05-31 EPS (Diluted) (USD per share) 2026-05-31

Paler bars were last filed before a stock split, on the old share basis.

Period endedEPS (Diluted)Change YoYSource filing
2026-05-31-$0.04n/m2026-07-30, From 2025-06-01
2025-05-31-$5.03n/m2026-07-30, From 2024-06-01
2024-05-31-$0.04n/m2026-07-30, From 2023-06-01
2023-05-31-$0.12n/m2025-07-30, From 2022-06-01
2022-05-31$0.45-21.1%2024-07-30, From 2021-06-01
2021-05-31$0.57+1.8%2023-08-15, From 2020-06-01
2020-05-31$0.56-1.8%2022-07-27, From 2019-06-01
2019-05-31$0.57n/c2021-07-30, From 2018-06-01
2018-05-31$1.21+40.7%2020-07-30, From 2017-06-01
2017-05-31$0.86+19.4%2019-07-30, From 2016-06-01
2016-05-31$0.72n/c2018-07-27, From 2015-06-01
2015-05-31$0.90+18.4%2017-07-28, From 2014-06-01
2014-05-31$0.76+1.3%2016-07-29, From 2013-06-01
2013-05-31$0.75+21.0%2015-07-30, From 2012-06-01
2012-05-31$0.62n/c2014-07-30, From 2011-06-01
2011-05-31$0.96+26.3%2013-07-30, From 2010-06-01
2010-05-31$0.76n/a2012-07-30, From 2009-06-01

EPS (Diluted) at similar companies

Companies with the same SEC industry code (In Vitro & In Vivo Diagnostic Substances), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEPS (Diluted)Change YoY
Neogen Corp (NEOG)2026-05-31-$0.04n/m
Myriad Genetics Inc (MYGN)2025-12-31-$3.95n/m
Lantheus Holdings, Inc. (LNTH)2025-12-31$3.41-21.8%
QuidelOrtho Corp (QDEL)2025-12-28-$16.69n/m
Idexx Laboratories Inc (IDXX)2025-12-31$13.08+22.6%
Intellia Therapeutics, Inc. (NTLA)2025-12-31-$3.81n/m
Alpha Teknova, Inc. (TKNO)2025-12-31-$0.32n/m
Immucell Corp (ICCC)2025-12-31-$0.12n/m
Aspira Women's Health Inc. (AWHL)2025-12-31-$0.37n/m

Compare NEOG, MYGN, LNTH, QDEL side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗